Business Description
DexTech Medical AB
ISIN : SE0005881489
Total Employee Number:
1Compare
Compare
Traded in other countries / regions
DEX.SwedenLQ0.Germany IPO Date
2014-06-19Description
DexTech Medical AB is a Swedish research company specializing in drug development for urological oncology, with a prominent focus on prostate cancer. The company develops drug candidates using a proprietary carbohydrate platform, advancing treatments aimed at castration-resistant prostate cancer and related conditions. Its operations center on research, development, and licensing of these drug candidates. It has four drug candidates: OsteoDex, SomaDex, PSMA-binding conjugates, and GuaDex.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.97 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 23.5 | |||||
3-Year EPS without NRI Growth Rate | 5.7 | |||||
3-Year FCF Growth Rate | 8.2 | |||||
3-Year Book Growth Rate | -13.9 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 44.39 | |||||
9-Day RSI | 46.76 | |||||
14-Day RSI | 48.51 | |||||
3-1 Month Momentum % | -7.77 | |||||
6-1 Month Momentum % | 2.7 | |||||
12-1 Month Momentum % | 25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 20.18 | |||||
Quick Ratio | 20.18 | |||||
Cash Ratio | 18.91 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -25.96 | |||||
ROA % | -25.72 | |||||
ROIC % | -60.75 | |||||
3-Year ROIIC % | -0.77 | |||||
ROC (Joel Greenblatt) % | -4828.24 | |||||
ROCE % | -27.04 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 9.4 | |||||
Price-to-Tangible-Book | 18.21 | |||||
EV-to-EBIT | -28.21 | |||||
EV-to-EBITDA | -34.82 | |||||
EV-to-FCF | -139.62 | |||||
Price-to-Projected-FCF | 113.33 | |||||
| Price-to-Net-Current-Asset-Value | 18.21 | |||||
| Price-to-Net-Cash | 19.62 | |||||
Earnings Yield (Greenblatt) % | -3.54 | |||||
FCF Yield % | -0.7 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
DexTech Medical AB Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | |||
| EPS (TTM) (kr) | -0.33 | ||
| Beta | -0.1125 | ||
| 3-Year Sharpe Ratio | 0.67 | ||
| 3-Year Sortino Ratio | 1.68 | ||
| Volatility % | 45.82 | ||
| 14-Day RSI | 48.51 | ||
| 14-Day ATR (kr) | 0.540034 | ||
| 20-Day SMA (kr) | 10.455 | ||
| 12-1 Month Momentum % | 25 | ||
| 52-Week Range (kr) | 5.85 - 14.4 | ||
| Shares Outstanding (Mil) | 18.49 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
DexTech Medical AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
DexTech Medical AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| General meeting for 2026 | 2026-11-04 10:00 | In 124 days | ||
| First quarter earnings results for 2027 | 2026-11-03 | In 122 days | ||
| Annual report for 2026 | 2026-09-18 | In 76 days | ||
| Fourth quarter earnings results for 2026 | 2026-08-31 | In 58 days | ||
| Third quarter earnings results for 2026 | 2026-05-05 | 10.10 (+3.91%) | ||
| Second quarter earnings results for 2026 | 2026-02-25 | 11.20 (+0.00%) | ||
| General meeting for 2025 | 2025-11-04 10:00 | 7.05 (+0.00%) | ||
| First quarter earnings results for 2026 | 2025-11-03 | 6.80 (-0.73%) | ||
| Annual report for 2025 | 2025-09-19 | 8.95 (+7.19%) | ||
| Fourth quarter earnings results for 2025 | 2025-08-30 | 8.65 (+1.17%) |
Show
Entries
DexTech Medical AB Frequently Asked Questions
What is DexTech Medical AB(XSAT:DEX)'s stock price today?
The current price of XSAT:DEX is kr10.20. The 52 week high of XSAT:DEX is kr14.40 and 52 week low is kr5.85.
When is next earnings date of DexTech Medical AB(XSAT:DEX)?
The next earnings date of DexTech Medical AB(XSAT:DEX) is 2026-08-31.
Does DexTech Medical AB(XSAT:DEX) pay dividends? If so, how much?
DexTech Medical AB(XSAT:DEX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on DexTech Medical AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers